| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70512-814-60 | 70512-814 | HUMAN PRESCRIPTION DRUG | COXANTO | oxaprozin | CAPSULE | ORAL | 20251103 | N/A | NDA | NDA217927 | SOLA Pharmaceuticals, LLC | OXAPROZIN | 300 mg/1 | 60 CAPSULE in 1 BOTTLE (70512-814-60) |
| 69499-403-60 | 69499-403 | HUMAN PRESCRIPTION DRUG | Coxanto | oxaprozin | CAPSULE | ORAL | 20231024 | N/A | NDA | NDA217927 | Solubiomix, LLC | OXAPROZIN | 300 mg/1 | 60 CAPSULE in 1 BOTTLE (69499-403-60) |
| 70512-787-60 | 70512-787 | HUMAN PRESCRIPTION DRUG | Oxaprozin | Oxaprozin | CAPSULE | ORAL | 20251203 | N/A | NDA | NDA217927 | SOLA Pharmaceuticals, LLC | OXAPROZIN | 300 mg/1 | 60 CAPSULE in 1 BOTTLE (70512-787-60) |
| 73308-403-60 | 73308-403 | HUMAN PRESCRIPTION DRUG | Oxaprozin | oxaprozin | CAPSULE | ORAL | 20231114 | N/A | NDA | NDA217927 | Ayurax, LLC | OXAPROZIN | 300 mg/1 | 60 CAPSULE in 1 BOTTLE (73308-403-60) |